Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV002389464 | SCV002697845 | likely pathogenic | Diamond-Blackfan anemia | 2016-01-11 | criteria provided, single submitter | clinical testing | The p.P47L variant (also known as c.140C>T), located in coding exon 2 of the RPS19 gene, results from a C to T substitution at nucleotide position 140. The proline at codon 47 is replaced by leucine, an amino acid with some similar properties. This variant has been identified in an individual diagnosed with Diamond Blackfan anemia at 2 months of age who had no malformations and was responsive to steroid therapy (Ramenghi U et al. Blood Cells Mol Dis. 2000;26(5):417-22). An in vitro functional study found this alteration resulted in protein that failed to associate with the ribosome (Angelini M et al. Hum Mol Genet. 2007;16(14):1720-7). This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. This amino acid position is highly conserved in available vertebrate species; however, leucine is the reference amino acid in hedgehog. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. |